• Fenipentol in Pancreatic Secretion & Fibrosis Research Workf

  2026-05-11

  Fenipentol (1-Phenyl-1-pentanol) uniquely bridges classic choleretic assays and emerging anti-fibrotic research. Discover robust, data-backed protocols and troubleshooting strategies to maximize reproducibility and experimental depth in gastrointestinal and hepatic studies.

• Forsythoside E (SKU N2883): Enhancing Cell Assay Reproducibi

  2026-05-11

  This article explores how Forsythoside E (SKU N2883) drives reproducible and mechanistically robust workflows in cell viability, proliferation, and cytotoxicity assays. Through scenario-driven analysis, we address practical lab challenges and demonstrate data-backed solutions for macrophage immunometabolism and inflammation research.

• Anlotinib Hydrochloride: Multi-Target Tyrosine Kinase Inhibi

  2026-05-10

  Anlotinib hydrochloride sets a new benchmark in cancer research as a multi-target tyrosine kinase inhibitor with nanomolar potency for angiogenesis assays. This guide details advanced experimental workflows, troubleshooting tactics, and actionable protocol parameters for maximizing assay performance with APExBIO’s Anlotinib hydrochloride.

• CAY10499: Precision Inhibitor of Human Hormone Sensitive Lip

  2026-05-09

  CAY10499 empowers researchers investigating lipid metabolism and immunometabolic crosstalk with robust, reproducible inhibition of HSL and MGL. Its selectivity and potency make it a superior reagent for dissecting fatty acid mobilization, steroidogenesis, and tumor microenvironment modulation in advanced workflows.

• Promethazine HCl in Research: Workflows, Innovations & Troub

  2026-05-09

  Promethazine HCl enables advanced studies in histaminergic signaling, inflammation, and macrophage antibacterial responses through its dual action on H1 receptor inhibition and cellular autophagy/ROS induction. This article delivers actionable protocol guidance, troubleshooting strategies, and insight into leveraging Promethazine HCl for immunology and neuroscience applications, with evidence-backed workflow recommendations.

• Z-VDVAD-FMK: Irreversible Caspase-2 Inhibitor for Apoptosis

  2026-05-08

  Z-VDVAD-FMK (benzyloxycarbonyl-Val-Asp(OMe)-Val-Ala-Asp(OMe)-fluoromethyl ketone) is a potent, cell-permeable, irreversible inhibitor of caspase-2. It blocks both caspase-driven mitochondrial cytochrome c release and downstream apoptotic markers in cellular models. This compound is a robust tool for dissecting caspase-2-dependent apoptosis and has defined solubility and handling properties for reproducible research.

• Cell lysis buffer for WB and IP: Protease/Phosphatase Protec

  2026-05-07

  Cell lysis buffer for WB and IP enables rapid, non-denaturing protein extraction from diverse biological samples, incorporating a robust protease and phosphatase inhibitor cocktail. This formulation preserves native protein-protein interactions, prevents degradation, and supports reproducible results in Western blot, immunoprecipitation, and related assays.

• Applied Use of KU-60019: ATM Kinase Inhibitor in Glioma Rese

  2026-05-07

  KU-60019, a potent ATM kinase inhibitor from APExBIO, redefines glioma research by enabling precise radiosensitization and metabolic vulnerability analysis. This guide delivers actionable workflows, troubleshooting strategies, and protocol enhancements based on cutting-edge evidence.

• Nocodazole as a Microtubule Polymerization Inhibitor: Mechan

  2026-05-06

  Explore the advanced mechanistic role of Nocodazole as a microtubule polymerization inhibitor, with a focus on practical assay decisions and nuanced cross-domain applications. This article delivers detailed scientific insights distinct from standard protocols.

• MEK/ERK Pathway Controls TERT Expression in Human Stem Cells

  2026-05-06

  The referenced study demonstrates how MEK1/2 kinases, in cooperation with c-Myc:MAX, prevent polycomb-mediated repression of TERT in human pluripotent stem cells. This reveals a direct mechanistic link between MAPK signaling and telomerase regulation, offering new insights for stem cell biology and disease modeling.

• Ciprofloxacin (hydrochloride): Reliable Assay Performance in

  2026-05-05

  This article addresses critical challenges in cell-based and bacterial viability assays by providing scenario-driven guidance on using Ciprofloxacin (hydrochloride) (SKU C5539). We examine its mechanistic strengths, solution stability, and sourcing reliability, supporting best practices with recent literature and actionable protocol parameters. APExBIO's offering is positioned as a trusted resource for reproducible, high-sensitivity research.

• Itraconazole in Translational Antifungal Research: Mechanism

  2026-05-05

  This thought-leadership article explores the mechanistic underpinnings and translational opportunities of Itraconazole, highlighting its multifaceted action as a triazole antifungal agent. Drawing on recent research into Candida biofilm resistance, autophagy, and drug interactions, the piece synthesizes evidence-based guidance for experimental design, competitive benchmarking, and strategic innovation. The article positions APExBIO’s Itraconazole as a catalyst for next-generation antifungal discovery, while differentiating itself from standard product pages by bridging mechanistic insights with actionable protocols and broader clinical implications.

• Protease Inhibitor Cocktail (EDTA-Free): Precision for Compl

  2026-05-04

  Explore the advanced science behind the Protease Inhibitor Cocktail (EDTA-Free, 100X in DMSO), a leading protein stability enhancer by APExBIO. This article reveals how its unique composition empowers high-fidelity proteome analysis in cutting-edge cancer metabolism research.

• Outer Membrane Vesicle mRNA Display for Personalized Tumor V

  2026-05-04

  This article examines a recent study introducing bacteria-derived outer membrane vesicles (OMVs) as a novel, rapid, and immunostimulatory delivery platform for mRNA antigens in personalized cancer vaccines. The findings demonstrate significant efficacy in antitumor immunity and highlight OMV-LL-mRNA’s potential advantages over lipid nanoparticle systems.

• SGC-CBP30: Optimizing CREBBP/EP300 Bromodomain Inhibition Wo

  2026-05-03

  SGC-CBP30 enables precise modulation of chromatin and transcriptional machinery, offering unique leverage in super-enhancer and TGF-β/SMAD3 pathway studies. Applied across epigenetics and cancer biology, its selective inhibition of CREBBP/EP300 bromodomains empowers advanced assay designs, particularly for dissecting early-stage lung adenocarcinoma mechanisms.

442 records 18/30 page Previous Next First page 上5页 1617181920 下5页 Last page